Public recall detail

Erwinase for Injection - Special Handling Instructions

medium
Recall Safety notice
Quick summary

Quick summary: Erwinase for Injection - Special Handling Instructions .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Erwinase for Injection - Special Handling Instructions .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Issue

During routine inspection of BATCH 180G, particulate matter was observed bound to the stopper and/or present on the lyophilized cake of some vials of ERWINASE. These affected vials were segregated. There is a possibility that some remaining vials may contain particulate matter bound to the stopper and/or on the lyophilized cake, which if transferred to reconstituted ERWINASE may pose a safety risk to patients. To avoid a potential shortage of ERWINASE, Health Canada has not objected to the importation of up to 150 packs of UK-labelled product from the global Batch CAMR-180G as an interim measure.

Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...